Table 1.
Laboratory findings from admission to discharge in pregnant woman with COVID‐19
| Variable | Normal range | Day 1 (admission) | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 (delivery) | Day 6 (postpartum) | Day 8 (discharge) |
|---|---|---|---|---|---|---|---|---|---|
| C‐reactive protein (mg/L) | < 5 | 49 | 63 | 48 | — | 14 | 9.8 | — | — |
| Hemoglobin (mmol/L) | 7.5–10.0 | 5.5 | 5.8 | 6.1 | 6.5 | 6.2 | 6.4 | 4.4 | 5.7 |
| Hematocrit (L/L) | 0.35–0.45 | 0.29 | 0.31 | 0.33 | 0.35 | 0.34 | 0.35 | 0.23 | — |
| Mean corpuscular volume (fL) | 80–100 | 77 | 77 | 77 | 77 | 77 | 78 | 77 | 80 |
| White blood cell count (109/L) | 4.0–10.0 | 4.8 | 3.9 | 5.1 | — | 8.5 | 9.3 | 10.3 | — |
| Platelet count (109/L) | 150–400 | 150 | 131 | 104 | 123 | 118 | 131 | 109 | 170 |
| APTT (s) | 25–34 | — | — | 45 | 39 | 38 | 36 | 34 | 35 |
| Prothrombin time (s) | 12.1–15.6 | — | — | 16.7 | 16.8 | 17.4 | 16.8 | 17 | 15.7 |
| Fibrinogen (g/L) | 2.0–4.0 | — | — | 1.2 | 1.0 | 0.7 | 0.9 | 1.7 | 4.2 |
| D‐dimer (mg/L) | < 0.50 | — | — | 27 | 20 | 9.4 | — | 2.6 | 0.41 |
| Creatinine (µmol/L) | 49–90 | 45 | 50 | 46 | 46 | 52 | 50 | 50 | — |
| eGFR (mL/m/1.73 m2) | > 90 | > 90 | > 90 | > 90 | > 90 | > 90 | > 90 | > 90 | — |
| Urate (mmol/L) | 0.12–0.34 | 0.18 | 0.21 | 0.22 | 0.22 | 0.24 | 0.23 | 0.25 | — |
| Aspartate aminotransferase (U/L) | < 31 | 24 | 35 | 37 | 36 | 29 | 32 | 62 | — |
| Alanine aminotransferase (U/L) | < 34 | 9 | 9 | 9 | 8 | 9 | 14 | 17 | — |
| Lactate dehydrogenase (U/L) | < 247 | 220 | 310 | 410 | 460 | 450 | 430 | 360 | — |
| Haptoglobin (g/L) | 0.37–2.21 | — | — | 1.72 | — | — | — | — | — |
| Protein–creatinine ratio (urine) (mg/mmol) | < 30 | 21 | — | — | < 11 | — | — | — | — |
| Albumin (g/L) | 35–50 | — | — | — | — | — | — | 28 | 29 |
| Corrected calcium (mmol/L) | 2.15–2.55 | — | — | — | — | — | — | 2.14 | 2.39 |
APTT, activated partial thromboplastin time; eGFR, estimated glomerular filtration rate.